Log In
Print
BCIQ
Print
Print this Print this
 

epinephrine auto-injector (Allerject, Auvi-Q)

  Manage Alerts
Collapse Summary General Information
Company kaleo Inc.
DescriptionEpinephrine auto-injector with visual and audio cues to guide users through the injection process
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices
Latest Stage of DevelopmentMarketed
Standard IndicationAllergy
Indication DetailsEmergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis
Regulatory Designation
Partner Sanofi

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$230.0M

$25.0M

$205.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today